Addiction, addiction-treatment / 28.03.2026

[caption id="attachment_72977" align="aligncenter" width="500"]Neuro-Restorative Continuity in SUD Treatment p[/caption] In the contemporary landscape of addiction medicine, the primary clinical challenge has shifted. While the management of acute withdrawal—once a high-risk hurdle—has become a relatively standardized pharmacological procedure, the true "research frontier" lies in the post-stabilization window. This is the critical period where neuroplasticity can either facilitate a return to homeostasis or solidify the neural pathways of relapse. The persistently high rates of recidivism in Substance Use Disorder (SUD) are frequently a byproduct of what researchers call "fragmented care." This occurs when a patient is medically detoxified in an isolated setting and then prematurely transitioned into a low-intensity environment before the brain’s reward circuitry has had the necessary time to recalibrate. This is why the conversation among clinical researchers is shifting toward the Integrated Longitudinal Model. In this context, a premier San Diego rehabilitation center serves as more than just a residential facility; it functions as a controlled, enriched environment for the phased restoration of the prefrontal cortex.
Addiction, Author Interviews / 20.10.2024

MedicalResearch.com Interview with: [caption id="attachment_64133" align="alignleft" width="158"]Karen Arscott, Dr. Arscott[/caption] Karen Arscott, DO Department of Medical Education Geisinger Commonwealth School of Medicine Scranton PA 18509 MedicalResearch.com: What is the background for this study? Response: “Substance Use Disorder Risk Assessment (SUDRA)” is a proposed screening tool and possible source of prevention for substance use disorder (SUD) and alcohol use disorder (AUD).  The US opioid overdose epidemic continues to escalate with over one-hundred thousand deaths in a single year. The current screening tools used for assessing SUD identifies persons already suffering with advanced disease. Our investigation brings to light a simple screening tool which can be used to identify a person with “Preaddiciton” potential. For many years I have asked persons (both patients and nonpatients) the question how they felt the first time they took an opioid. Their answers have been astonishing. Probably the one answer that struck me the strongest was a professional colleague who answered that when she was prescribed Vicodin following a surgical procedure it made her feel so amazing that it scared her, and she never took another opioid. She reported to me that it would have been too easy to take regularly for the wonderful feeling – she however, recognized the danger of that feeling and avoided a potential substance use disorder. What if this risk was provided to all – what if parents and patients understood the risk if faced with that “feeling”? How many lives could be saved? We are very confident that these timely findings will be discussed and presented widely. The paper will be highly downloaded and cited by many interested in the prevention of substance use disorder – a new concept and much improved over the current treatment of advanced disease.